BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35838370)

  • 1. Environmental and occupational exposures in interstitial lung disease.
    Lee CT; Feary J; Johannson KA
    Curr Opin Pulm Med; 2022 Sep; 28(5):414-420. PubMed ID: 35838370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.
    Copeland CR; Collins BF; Salisbury ML
    Chest; 2021 Jul; 160(1):219-230. PubMed ID: 33609518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Occupational and Environmental Exposures in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Narrative Literature Review.
    Trethewey SP; Walters GI
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.
    Lee CT; Adegunsoye A; Chung JH; Ventura IB; Jablonski R; Montner S; Vij R; Hines SE; Strek ME
    Chest; 2021 Jul; 160(1):209-218. PubMed ID: 33621598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work-related interstitial lung disease: what is the true burden?
    De Matteis S; Murgia N
    Int J Tuberc Lung Dis; 2022 Nov; 26(11):1001-1005. PubMed ID: 36281049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
    Dodia N; Amariei D; Kenaa B; Corwin D; Chelala L; Britt EJ; Sachdeva A; Luzina IG; Hasday JD; Shah NG; Atamas SP; Franks TJ; Burke AP; Hines SE; Galvin JR; Todd NW
    Respir Med; 2021 Apr; 179():106333. PubMed ID: 33676119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
    Lee CT; Strek ME; Adegunsoye A; Wong AW; Assayag D; Cox G; Fell CD; Fisher JH; Gershon AS; Halayko AJ; Hambly N; Khalil N; Kolb M; Lok SD; Manganas H; Marcoux V; Morisset J; Sadatsafavi M; Shapera S; To T; Wilcox P; Ryerson CJ; Johannson KA
    Respirology; 2022 Aug; 27(8):635-644. PubMed ID: 35512793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
    Gandhi SA; Min B; Fazio JC; Johannson KA; Steinmaus C; Reynolds CJ; Cummings KJ
    Ann Am Thorac Soc; 2024 Mar; 21(3):486-498. PubMed ID: 38096107
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research progress of occupational and environmental exposure and idiopathic pulmonary fibrosis].
    Guo ZY; Ye Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Oct; 40(10):790-794. PubMed ID: 36348566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial Lung Diseases in Developing Countries.
    Rivera-Ortega P; Molina-Molina M
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
    Abramson MJ; Murambadoro T; Alif SM; Benke GP; Dharmage SC; Glaspole I; Hopkins P; Hoy RF; Klebe S; Moodley Y; Rawson S; Reynolds PN; Wolfe R; Corte TJ; Walters EH;
    Thorax; 2020 Oct; 75(10):864-869. PubMed ID: 32660982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposures and idiopathic pulmonary fibrosis.
    Walters GI
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):103-111. PubMed ID: 31895128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-Induced Pulmonary Fibrosis.
    Assad N; Sood A; Campen MJ; Zychowski KE
    Curr Environ Health Rep; 2018 Dec; 5(4):486-498. PubMed ID: 30298344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental Causes of Idiopathic Pulmonary Fibrosis.
    Gandhi S; Tonelli R; Murray M; Samarelli AV; Spagnolo P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
    Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
    Elhai M; Avouac J; Allanore Y
    Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrotic interstitial lung diseases and air pollution: a systematic literature review.
    Harari S; Raghu G; Caminati A; Cruciani M; Franchini M; Mannucci P
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 32817115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.